BioCardia receives Nasdaq notice for trading below $1 minimum bid price requirement - BCDA News | RalliesBioCardia receives Nasdaq notice for trading below $1 minimum bid price requirement
B
BCDA• Nasdaq notice for minimum bid price deficiency
- BioCardia received a Nasdaq notice on Aug. 19, 2026 for failing the $1 minimum bid price rule for 30 consecutive sessions.
- The stock has until Feb. 16, 2027 to regain compliance by closing at $1 or more for 10 consecutive business days.
- Non-compliance could trigger a delisting process, with a possible second 180-day cure period if listing standards are met.
Company monitoring options to restore compliance
- Management is monitoring the share price, with a reverse stock split among potential options to restore compliance.
HRTG
•
